PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of canfamphysLink to Publisher's site
 
Can Fam Physician. 1999 November; 45: 2672–2679.
PMCID: PMC2328686

Anxiety disorders in late life.

Abstract

OBJECTIVE: To review the epidemiology, clinical characteristics, and treatment of anxiety disorders in late life. QUALITY OF EVIDENCE: Epidemiologic and comorbidity data are derived from well designed random-sample community surveys. There are virtually no controlled data specific to treatment of anxiety in the elderly. Guidelines for treating anxiety disorders in late life, therefore, must be extrapolated from results of randomized controlled trials conducted in younger patients. MAIN MESSAGE: Generalized anxiety disorder and agoraphobia account for most cases of anxiety disorder in late life. Late-onset generalized anxiety is usually associated with depressive illness and, in this situation, the primary pharmacologic treatment is antidepressant medication. Most elderly people with agoraphobia do not give a history of panic attacks; exposure therapy is the preferred treatment for agoraphobia without panic. CONCLUSIONS: Physicians need to make more use of antidepressant medication and behavioural therapy and less use of benzodiazepines in treating anxiety disorders in late life.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.9M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Flint AJ. Epidemiology and comorbidity of anxiety disorders in the elderly. Am J Psychiatry. 1994 May;151(5):640–649. [PubMed]
  • Regier DA, Boyd JH, Burke JD, Jr, Rae DS, Myers JK, Kramer M, Robins LN, George LK, Karno M, Locke BZ. One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites. Arch Gen Psychiatry. 1988 Nov;45(11):977–986. [PubMed]
  • Kennedy BL, Schwab JJ. Utilization of medical specialists by anxiety disorder patients. Psychosomatics. 1997 Mar-Apr;38(2):109–112. [PubMed]
  • Lindesay J, Briggs K, Murphy E. The Guy's/Age Concern survey. Prevalence rates of cognitive impairment, depression and anxiety in an urban elderly community. Br J Psychiatry. 1989 Sep;155:317–329. [PubMed]
  • Forsell Y, Winblad B. Feelings of anxiety and associated variables in a very elderly population. Int J Geriatr Psychiatry. 1998 Jul;13(7):454–458. [PubMed]
  • Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Fam Med. 1997 Jan-Feb;6(1):43–49. [PubMed]
  • Moser DK, Dracup K. Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events? Psychosom Med. 1996 Sep-Oct;58(5):395–401. [PubMed]
  • Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation. 1994 Nov;90(5):2225–2229. [PubMed]
  • Bland RC, Newman SC, Orn H. Prevalence of psychiatric disorders in the elderly in Edmonton. Acta Psychiatr Scand Suppl. 1988;338:57–63. [PubMed]
  • Uhlenhuth EH, Balter MB, Mellinger GD, Cisin IH, Clinthorne J. Symptom checklist syndromes in the general population. Correlations with psychotherapeutic drug use. Arch Gen Psychiatry. 1983 Nov;40(11):1167–1173. [PubMed]
  • Copeland JR, Dewey ME, Wood N, Searle R, Davidson IA, McWilliam C. Range of mental illness among the elderly in the community. Prevalence in Liverpool using the GMS-AGECAT package. Br J Psychiatry. 1987 Jun;150:815–823. [PubMed]
  • Copeland JR, Gurland BJ, Dewey ME, Kelleher MJ, Smith AM, Davidson IA. Is there more dementia, depression and neurosis in New York? A comparative study of the elderly in New York and London using the computer diagnosis AGECAT. Br J Psychiatry. 1987 Oct;151:466–473. [PubMed]
  • Lindesay J. Phobic disorders in the elderly. Br J Psychiatry. 1991 Oct;159:531–541. [PubMed]
  • Klein DF. Anxiety reconceptualized. Compr Psychiatry. 1980 Nov-Dec;21(6):411–427. [PubMed]
  • Menza MA, Robertson-Hoffman DE, Bonapace AS. Parkinson's disease and anxiety: comorbidity with depression. Biol Psychiatry. 1993 Oct 1;34(7):465–470. [PubMed]
  • Flint AJ, Rifat SL. Two-year outcome of elderly patients with anxious depression. Psychiatry Res. 1997 Jan 15;66(1):23–31. [PubMed]
  • Sheikh JI, King RJ, Taylor CB. Comparative phenomenology of early-onset versus late-onset panic attacks: a pilot survey. Am J Psychiatry. 1991 Sep;148(9):1231–1233. [PubMed]
  • Raj BA, Corvea MH, Dagon EM. The clinical characteristics of panic disorder in the elderly: a retrospective study. J Clin Psychiatry. 1993 Apr;54(4):150–155. [PubMed]
  • Kuch K, Cox BJ. Symptoms of PTSD in 124 survivors of the Holocaust. Am J Psychiatry. 1992 Mar;149(3):337–340. [PubMed]
  • Robinson S, Rapaport J, Durst R, Rapaport M, Rosca P, Metzer S, Zilberman L. The late effects of Nazi persecution among elderly Holocaust survivors. Acta Psychiatr Scand. 1990 Oct;82(4):311–315. [PubMed]
  • Kluznik JC, Speed N, Van Valkenburg C, Magraw R. Forty-year follow-up of United States prisoners of war. Am J Psychiatry. 1986 Nov;143(11):1443–1446. [PubMed]
  • Sutker PB, Allain AN, Jr, Winstead DK. Psychopathology and psychiatric diagnoses of World War II Pacific theater prisoner of war survivors and combat veterans. Am J Psychiatry. 1993 Feb;150(2):240–245. [PubMed]
  • Macleod AD. The reactivation of post-traumatic stress disorder in later life. Aust N Z J Psychiatry. 1994 Dec;28(4):625–634. [PubMed]
  • Goenjian AK, Najarian LM, Pynoos RS, Steinberg AM, Manoukian G, Tavosian A, Fairbanks LA. Posttraumatic stress disorder in elderly and younger adults after the 1988 earthquake in Armenia. Am J Psychiatry. 1994 Jun;151(6):895–901. [PubMed]
  • Jenike MA. Geriatric obsessive-compulsive disorder. J Geriatr Psychiatry Neurol. 1991 Jan-Mar;4(1):34–39. [PubMed]
  • Kohn R, Westlake RJ, Rasmussen SA, Marsland RT, Norman WH. Clinical features of obsessive-compulsive disorder in elderly patients. Am J Geriatr Psychiatry. 1997 Summer;5(3):211–215. [PubMed]
  • Blanchard MR, Waterreus A, Mann AH. The nature of depression among older people in inner London, and the contact with primary care. Br J Psychiatry. 1994 Mar;164(3):396–402. [PubMed]
  • Forsell Y, Winblad B. Anxiety disorders in non-demented and demented elderly patients: prevalence and correlates. J Neurol Neurosurg Psychiatry. 1997 Mar;62(3):294–295. [PMC free article] [PubMed]
  • Man GC, Hsu K, Sproule BJ. Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease. Chest. 1986 Dec;90(6):832–836. [PubMed]
  • Calamari JE, Faber SD, Hitsman BL, Poppe CJ. Treatment of obsessive compulsive disorder in the elderly: a review and case example. J Behav Ther Exp Psychiatry. 1994 Jun;25(2):95–104. [PubMed]
  • Leng N. A brief review of cognitive-behavioural treatments in old age. Age Ageing. 1985 Sep;14(5):257–263. [PubMed]
  • Rocca P, Fonzo V, Scotta M, Zanalda E, Ravizza L. Paroxetine efficacy in the treatment of generalized anxiety disorder. Acta Psychiatr Scand. 1997 May;95(5):444–450. [PubMed]
  • Austin LS, Zealberg JJ, Lydiard RB. Three cases of pharmacotherapy of obsessive-compulsive disorder in the elderly. J Nerv Ment Dis. 1991 Oct;179(10):634–635. [PubMed]
  • De Boer M, Op den Velde W, Falger PJ, Hovens JE, De Groen JH, Van Duijn H. Fluvoxamine treatment for chronic PTSD: a pilot study. Psychother Psychosom. 1992;57(4):158–163. [PubMed]
  • Steinberg JR. Anxiety in elderly patients. A comparison of azapirones and benzodiazepines. Drugs Aging. 1994 Nov;5(5):335–345. [PubMed]
  • Gilbert A, Owen N, Innes JM, Sansom L. Trial of an intervention to reduce chronic benzodiazepine use among residents of aged-care accommodation. Aust N Z J Med. 1993 Aug;23(4):343–347. [PubMed]
  • Rickels K, Schweizer E, Csanalosi I, Case WG, Chung H. Long-term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspirone. Arch Gen Psychiatry. 1988 May;45(5):444–450. [PubMed]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada